Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 102
of 6Next
1:
Rosner B, Colditz GA, Iglehart JD, Hankinson SE.
Free in PMC
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study.
Breast Cancer Res. 2008;10(4):R55. Epub 2008 Jul 3.
PMID: 18598349 [PubMed - in process]
2:
Tamimi RM, Byrne C, Colditz GA, Hankinson SE.
Free Full Text
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.
PMID: 17652278 [PubMed - indexed for MEDLINE]
3:
Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
Free Full Text
Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.
PMID: 15840882 [PubMed - indexed for MEDLINE]
4:
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS.
Abstract
A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
J Natl Cancer Inst. 1995 Feb 1;87(3):190-7.
PMID: 7707406 [PubMed - indexed for MEDLINE]
5:
Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE.
Free Full Text
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9.
PMID: 9731736 [PubMed - indexed for MEDLINE]
6:
Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE.
Abstract
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
J Clin Oncol. 2006 Apr 20;24(12):1823-30. Epub 2006 Mar 27.
PMID: 16567770 [PubMed - indexed for MEDLINE]
7:
Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
Free Full Text
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.
PMID: 17018787 [PubMed - indexed for MEDLINE]
8:
Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.
Free Full Text
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.
PMID: 16959170 [PubMed - indexed for MEDLINE]
9:
Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, Strax P, Pasternack BS.
Free Full Text
Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):857-60.
PMID: 8634657 [PubMed - indexed for MEDLINE]
10:
Rosner B, Colditz GA.
Free Full Text
Nurses' health study: log-incidence mathematical model of breast cancer incidence.
J Natl Cancer Inst. 1996 Mar 20;88(6):359-64.
PMID: 8609645 [PubMed - indexed for MEDLINE]
11:
Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
Free Full Text
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.
PMID: 15601642 [PubMed - indexed for MEDLINE]
12:
Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.
Free Full Text
Risk factors for breast cancer according to estrogen and progesterone receptor status.
J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.
PMID: 14759989 [PubMed - indexed for MEDLINE]
13:
Cummings SR, Duong T, Kenyon E, Cauley JA, Whitehead M, Krueger KA; Multiple Outcomes of Raloxifene Evaluation (MORE) Trial.
Free Full Text
Serum estradiol level and risk of breast cancer during treatment with raloxifene.
JAMA. 2002 Jan 9;287(2):216-20.
PMID: 11779264 [PubMed - indexed for MEDLINE]
14:
Rockhill B, Byrne C, Rosner B, Louie MM, Colditz G.
Abstract
Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.
J Clin Epidemiol. 2003 Sep;56(9):856-61.
PMID: 14505770 [PubMed - indexed for MEDLINE]
15:
Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.
Free Full Text
Prospective breast cancer risk prediction model for women undergoing screening mammography.
J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.
PMID: 16954473 [PubMed - indexed for MEDLINE]
16:
Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
Free Full Text
Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.
PMID: 16418513 [PubMed - indexed for MEDLINE]
17:
Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE.
Free Full Text
Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Cancer Res. 2004 Sep 15;64(18):6814-9.
PMID: 15375001 [PubMed - indexed for MEDLINE]
18:
Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, Longcope C, Speizer FE.
Abstract
Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States).
Cancer Causes Control. 1995 May;6(3):217-24.
PMID: 7612801 [PubMed - indexed for MEDLINE]
19:
Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.
Free Full Text
HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9.
PMID: 14973105 [PubMed - indexed for MEDLINE]
20:
Spiegelman D, Colditz GA, Hunter D, Hertzmark E.
Abstract
Validation of the Gail et al. model for predicting individual breast cancer risk.
J Natl Cancer Inst. 1994 Apr 20;86(8):600-7.
PMID: 8145275 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 102
of 6Next